This Crispr Therapeutics Stock: Why It Fell Today So Far
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
Understand what makes a good financial plan and how it can guide your business decisions. Create a plan that drives your success.
23,277 articlesBiotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
A veteran Wall Street analyst sees Delta Air Lines climbing roughly 50% in 2026, backed by fuel-efficiency gains and ...
Markets watch the debt path as deficits and entitlement costs rise. A budget watchdog warns that the current calm cou...
PayPal has fallen sharply from its peak. This guide explains how to evaluate a potential dip buy, weighing risk, fund...
Sri Lanka has moved to a four-day workweek, declaring Wednesdays a nationwide holiday to curb fuel use as oil shipmen...
Geopolitics and energy markets collide as Iran-related headlines drive price moves. Investors are reassessing risk, h...
A new anti-spam proposal at the heart of Bitcoin’s governance debate has sparked a power struggle, with analysts ques...
As gas prices trend higher, Costco’s fuel discounts and bulk-buying model could attract more shoppers. This practical...
Northcoast downgraded Norwegian Cruise Line amid macro headwinds, signaling tougher times for the sector as Middle Ea...
Nine months after Jim Cramer touted Energy Transfer as a top dividend pick for retirees, the stock has delivered on i...
Investors are watching Cytek's 2026 earnings story unfold after Q1 results. This deep dive breaks down the key driver...
A new round of claims alleges harassment at Carta, the private equity software unicorn valued near $7.4 billion. As m...